Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Croda International ( (GB:CRDA) ) just unveiled an announcement.
Croda International Plc announced a transaction involving Mrs. Sandra Elaine Breene, a member of its Executive Committee. The transaction involved the reinvestment of dividends into ordinary shares, with a total aggregated volume of 5 shares at a price of £154.00. This notification highlights the company’s ongoing efforts to maintain transparency in its financial dealings and may impact stakeholder perceptions regarding executive management’s commitment to the company’s growth.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on GB:CRDA Stock
According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Neutral.
Croda International exhibits strong financial stability and positive corporate developments. However, declining revenue and pressure on profit margins present challenges. The stock’s technical indicators suggest caution, but the fair valuation and positive corporate events offer support. Investors should be mindful of current challenges in revenue and profitability.
To see Spark’s full report on GB:CRDA stock, click here.
More about Croda International
Croda International Plc operates in the specialty chemicals industry, focusing on the production of high-performance ingredients and technologies that are used in a wide range of markets, including personal care, health care, crop care, and industrial specialties.
Average Trading Volume: 528,441
Technical Sentiment Signal: Sell
Current Market Cap: £4.29B
Learn more about CRDA stock on TipRanks’ Stock Analysis page.